Sepsis is the most common disease in the intensive care unit, and mortality rates from 40% to 70% if not detected early and treated. Although early diagnosis and early treatment are important prognostic factors, no effective
screening methods have been developed.
JW strives to develop diagnostic reagent enabling quick and accurate diagnosis before progress to sepsis.
Current goal is to develop reliable diagnostic kit capable of early diagnosis and mortality prediction of sepsis.